Latest Insider Transactions at Crispr Therapeutics Ag (CRSP)
This section provides a real-time view of insider transactions for Crispr Therapeutics Ag (CRSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CRISPR Therapeutics AG to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CRISPR Therapeutics AG's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2017
|
Celgene Corp /De/ > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,907
-0.32%
|
$253,419
$17.19 P/Share
|
|
Nov 13
2017
|
Celgene Corp /De/ > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
65,093
-1.4%
|
$1,106,581
$17.76 P/Share
|
|
Nov 10
2017
|
Celgene Corp /De/ > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000
-0.21%
|
$170,000
$17.28 P/Share
|
|
Nov 09
2017
|
Celgene Corp /De/ > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,000
-0.43%
|
$340,000
$17.08 P/Share
|
|
Nov 08
2017
|
Celgene Corp /De/ > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
16,875
-0.36%
|
$303,750
$18.06 P/Share
|
|
Nov 07
2017
|
Celgene Corp /De/ > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
23,000
-0.49%
|
$414,000
$18.54 P/Share
|
|
Nov 06
2017
|
Celgene Corp /De/ > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
79,327
-1.65%
|
$1,427,886
$18.89 P/Share
|
|
Nov 03
2017
|
Celgene Corp /De/ > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
22,759
-0.47%
|
$432,421
$19.1 P/Share
|
|
Sep 05
2017
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
55,447
+50.0%
|
-
|
|
Sep 05
2017
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
2,614,157
-55.55%
|
-
|
|
Sep 05
2017
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
311,052
+50.0%
|
-
|
|
Sep 05
2017
|
Thomas Woiwode Director |
BUY
Other acquisition or disposition
|
Direct |
9,918
+50.0%
|
-
|
|
Sep 05
2017
|
Thomas Woiwode Director |
SELL
Other acquisition or disposition
|
Indirect |
2,614,157
-55.55%
|
-
|
|
Sep 05
2017
|
Thomas Woiwode Director |
BUY
Other acquisition or disposition
|
Indirect |
311,052
+50.0%
|
-
|
|
Sep 05
2017
|
Versant Venture Capital Iv, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
2,614,157
-55.55%
|
-
|
|
Sep 05
2017
|
Versant Venture Capital Iv, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
311,052
+50.0%
|
-
|
|
Sep 05
2017
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
3,853
-0.33%
|
$77,060
$20.33 P/Share
|
|
Sep 05
2017
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,853
+0.33%
|
$3,853
$1.81 P/Share
|
|
Aug 31
2017
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
14,617
-1.26%
|
$292,340
$20.87 P/Share
|
|
Aug 30
2017
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-3.61%
|
$80,000
$20.0 P/Share
|
|
Aug 30
2017
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
58,103
-4.76%
|
$1,162,060
$20.31 P/Share
|
|
Aug 30
2017
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,722
+0.47%
|
$5,722
$1.81 P/Share
|
|
Aug 28
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
88,011
-4.32%
|
$1,672,209
$19.79 P/Share
|
|
Aug 28
2017
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,154
-17.27%
|
$463,080
$20.09 P/Share
|
|
Aug 28
2017
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
17,692
-1.44%
|
$353,840
$20.06 P/Share
|
|
Aug 28
2017
|
Rodger Novak President |
BUY
Exercise of conversion of derivative security
|
Direct |
17,692
+1.41%
|
$17,692
$1.81 P/Share
|
|
Aug 25
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
14,913
-0.73%
|
$283,347
$19.52 P/Share
|
|
Aug 24
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
7,868
-0.38%
|
$149,492
$19.23 P/Share
|
|
Aug 23
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
7,035
-0.34%
|
$126,630
$18.53 P/Share
|
|
Aug 22
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
10,954
-0.53%
|
$197,172
$18.53 P/Share
|
|
Aug 21
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
1,250
-0.06%
|
$22,500
$18.51 P/Share
|
|
Aug 18
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
1,900
-0.09%
|
$34,200
$18.53 P/Share
|
|
Aug 17
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
13,593
-0.65%
|
$244,674
$18.74 P/Share
|
|
Aug 16
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
20,548
-0.97%
|
$390,412
$19.27 P/Share
|
|
Aug 15
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
25,586
-1.19%
|
$486,134
$19.53 P/Share
|
|
Aug 14
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
29,983
-1.38%
|
$569,677
$19.64 P/Share
|
|
Aug 08
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
19,850
-0.9%
|
$357,300
$18.71 P/Share
|
|
Aug 08
2017
|
Tyler Dylan Hyde Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,313
-0.85%
|
$23,634
$18.6 P/Share
|
|
Aug 07
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
15,623
-0.7%
|
$281,214
$18.53 P/Share
|
|
Aug 07
2017
|
Tyler Dylan Hyde Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,210
-7.88%
|
$237,780
$18.56 P/Share
|
|
Aug 04
2017
|
Tyler Dylan Hyde Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
477
-0.28%
|
$8,586
$18.55 P/Share
|
|
Aug 04
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
3,068
-0.14%
|
$55,224
$18.5 P/Share
|
|
Aug 03
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
47,409
-2.08%
|
$805,953
$17.77 P/Share
|
|
Aug 01
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
264
-0.01%
|
$4,488
$17.5 P/Share
|
|
Jul 31
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
5,248
-0.23%
|
$89,216
$17.51 P/Share
|
|
Jul 28
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
400
-0.02%
|
$6,800
$17.65 P/Share
|
|
Jul 27
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
40,912
-1.76%
|
$695,504
$17.62 P/Share
|
|
Jul 26
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
23,744
-1.01%
|
$403,648
$17.63 P/Share
|
|
Jul 25
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
9,186
-0.39%
|
$156,162
$17.52 P/Share
|
|
Jul 14
2017
|
Kurt Von Emster Director |
SELL
Open market or private sale
|
Indirect |
36,230
-1.51%
|
$579,680
$16.82 P/Share
|